QIAGEN (Suzhou) Translational Medicine Co

 
Contact

About QIAGEN (Suzhou) Translational Medicine Co

QIAGEN (Suzhou) Translational Medicine Co. (TMC) Ltd. is the first diagnostic R&D company focused on translational science in China. The company provides complete solutions for precision medicine through translational science. Jointly established by QIAGEN and China SIP Biotechnology Development Co. Ltd., QIAGEN (Suzhou) TMC’s mission is the development and validation of biomarkers and companion diagnostics as well as patient stratification for clinical trials.

Therapeutic Areas

Infectious

Technologies

Diagnostics Drug delivery

Company Type

Biotechnology – Diagnostics

State of Ownership

Other

Influencer Of

Rambod Barzigar

NIAID Technology Transfer and Intellectual Property Office

Najoua Borkadi

Business Development Associate Director, University of Michigan

Albany A. Cordova Martins

Business Development Executive, Nature Publishing Group, Springer Nature

Carmen Ramirez

Sales Account Executive, Springer Nature

Emma Pickup

Account Executive, Sciad Communications

ALEXIOS-FOTIOS MENTIS

Medical doctor at National and Kapodistrian University of Athens, National and Kapodistrian University of Athens

Debayan Bose

Student, Academia Sinica

Jen Thoroughgood

Former Head of Communities, Springer Nature

Jenefer Thoroughgood

Managing Director, Thoroughly Good Consulting

Matt Kay

Product Manager, Nature Publishing Group

Claire Thompson

Global Manager, Business Development, Nature Publishing Group

Popular Contributions

Online Elsewhere

Experts Like QIAGEN (Suzhou) Translational Medicine Co

GSK

Mediphage Bioceuticals

Dark Horse Consulting

ImmuneMed Inc.

Aptorum

Content From Similar Experts